Gabapentin

Product NDC: 71093-121
11-digit product format: 710930121
Labeler code: 71093
Product ID: 71093-121_a916797c-381c-4008-b778-19221233ef45
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: ACI Healthcare USA, Inc.
Application: ANDA206943
Marketing category: ANDA
Marketing start: 2018-05-14
Substance: GABAPENTIN
Active strength: 300 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A206943-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14
A206943-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14
A206943-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A206943-001	AB
A206943-002	AB
A206943-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2018-05-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2018-05-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206943-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2018-05-14	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A206943-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206943-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206943-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206943-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206943-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206943-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206943-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206943-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206943-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206943-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206943-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206943-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206943-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206943-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206943-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206943-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206943-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206943-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206943-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206943-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206943-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206943-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: Gabapentin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7538e255-95df-4991-aae0-a90d709f1e95	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
7792dadb-52b6-46b6-8fdf-80b1171065b5	Product name	1	20180810
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71093-121-04	Gabapentin	100 in 1 BOTTLE, PLASTIC	CAPSULE	100		9
71093-121-05	Gabapentin	500 in 1 BOTTLE, PLASTIC	CAPSULE	500		9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71093-121-04	EA - Each	71093-121	03ceaf72-5ea0-4947-afe8-f8ddeac27fd0	1	2018-08-13
71093-121-05	EA - Each	71093-121	6cbe8b9b-8b03-4776-bd0e-482458fc0b3b	1	2018-08-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71093-121	GABAPENTIN CAPSULE [ACI HEALTHCARE USA, INC.]	9	Current NDC, Legacy NDC, 2 package rows	20231218_7538e255-95df-4991-aae0-a90d709f1e95.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 26 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	57492b91-1fe2-74ab-e063-6394a90a0b9e	2026-07-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	3c585b71-5cfc-18d6-e063-6294a90a3dcf	2026-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	4ddcdff5-8f1f-bff3-e063-6294a90a1195	2026-07-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	f93eaa4f-cc1a-10ab-e053-6394a90a5ffc	2026-06-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	St Mary's Medical Park Pharmacy	de990f96-96bc-406d-e053-2995a90abebb	2026-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Preferred Pharmaceuticals Inc.	6ecf5114-2ddc-4025-a36d-1884702dc22a	2026-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Preferred Pharmaceuticals Inc.	f396ec70-826d-45c6-a27c-343c2fac878c	2026-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Strides Pharma Science Limited	798575b9-ddfa-4915-9574-626abbaf025f	2026-04-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	REMEDYREPACK INC.	167d8b87-506c-4293-9579-563feaa71583	2025-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25	2025-07-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Direct_Rx	f40a4ee4-ae8e-769c-e053-2a95a90a344e	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	ADVANCED RX OF TENNESSEE, LLC	af73fbd8-9731-e6bf-e053-2995a90af65d	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	fb0b6613-57d6-4e24-946f-f5f87c460cf0	2024-10-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	ef37f2a0-3b83-4f71-91c0-6435161b483c	2024-10-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	NuCare Pharmaceuticals,Inc.	8e6ed5d2-40e0-1f06-e053-2a95a90aa40e	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	NuCare Pharmaceuticals,Inc.	ed219efc-84e3-5bdc-e053-2a95a90a56fc	2024-04-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	38210141-bbdc-4186-b71f-54c72f794dca	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	75418d32-6504-4cb4-b3a9-afa0eaf19b8d	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	1ec656c9-034f-4f14-9e6b-9779d41e1627	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	8de89818-805a-4a20-a9b1-48cf443b6315	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206943 application number: ANDA206943

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310431	gabapentin 300 MG Oral Capsule	PSN	fb0b6613-57d6-4e24-946f-f5f87c460cf0	104
310431	gabapentin 300 MG Oral Capsule	SCD	fb0b6613-57d6-4e24-946f-f5f87c460cf0	104
310431	gabapentin 300 MG Oral Capsule	PSN	9efd0261-9fc9-4dc9-8cf3-9110157ddfc4	101
310431	gabapentin 300 MG Oral Capsule	SCD	9efd0261-9fc9-4dc9-8cf3-9110157ddfc4	101
310431	gabapentin 300 MG Oral Capsule	PSN	01b810b7-f4c8-4412-bbc5-b9220d8770d8	11
310431	gabapentin 300 MG Oral Capsule	SCD	01b810b7-f4c8-4412-bbc5-b9220d8770d8	11
310430	gabapentin 100 MG Oral Capsule	PSN	7538e255-95df-4991-aae0-a90d709f1e95	9
310431	gabapentin 300 MG Oral Capsule	PSN	7538e255-95df-4991-aae0-a90d709f1e95	9
310432	gabapentin 400 MG Oral Capsule	PSN	7538e255-95df-4991-aae0-a90d709f1e95	9
310430	gabapentin 100 MG Oral Capsule	SCD	7538e255-95df-4991-aae0-a90d709f1e95	9
310431	gabapentin 300 MG Oral Capsule	SCD	7538e255-95df-4991-aae0-a90d709f1e95	9
310432	gabapentin 400 MG Oral Capsule	SCD	7538e255-95df-4991-aae0-a90d709f1e95	9
310431	gabapentin 300 MG Oral Capsule	PSN	af73fbd8-9731-e6bf-e053-2995a90af65d	5
310431	gabapentin 300 MG Oral Capsule	SCD	af73fbd8-9731-e6bf-e053-2995a90af65d	5
310431	gabapentin 300 MG Oral Capsule	PSN	1ec656c9-034f-4f14-9e6b-9779d41e1627	4
310431	gabapentin 300 MG Oral Capsule	SCD	1ec656c9-034f-4f14-9e6b-9779d41e1627	4
310431	gabapentin 300 MG Oral Capsule	PSN	de990f96-96bc-406d-e053-2995a90abebb	3
310431	gabapentin 300 MG Oral Capsule	PSN	ed219efc-84e3-5bdc-e053-2a95a90a56fc	3
310431	gabapentin 300 MG Oral Capsule	SCD	de990f96-96bc-406d-e053-2995a90abebb	3
310431	gabapentin 300 MG Oral Capsule	SCD	ed219efc-84e3-5bdc-e053-2a95a90a56fc	3
310431	gabapentin 300 MG Oral Capsule	PSN	edc2cf85-4f80-65d2-e053-2995a90aed3c	2
310431	gabapentin 300 MG Oral Capsule	PSN	167d8b87-506c-4293-9579-563feaa71583	2
310431	gabapentin 300 MG Oral Capsule	SCD	edc2cf85-4f80-65d2-e053-2995a90aed3c	2
310431	gabapentin 300 MG Oral Capsule	SCD	167d8b87-506c-4293-9579-563feaa71583	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71093-121-04	71093012104	100 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-04)	100 capsule	2018-08-04	0000-00-00	No	No	Current
71093-121-05	71093012105	500 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-05)	500 capsule	2018-08-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Gabapentin	St Mary's Medical Park Pharmacy	2026-05-01	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	REMEDYREPACK INC.	2025-07-30	HUMAN PRESCRIPTION DRUG LABEL	2
Gabapentin	Preferred Pharmaceuticals Inc.	2025-06-04	HUMAN PRESCRIPTION DRUG LABEL	2
Gabapentin Capsules	ADVANCED RX OF TENNESSEE, LLC	2024-12-31	HUMAN PRESCRIPTION DRUG LABEL	5
Gabapentin	Bryant Ranch Prepack	2024-10-18	HUMAN PRESCRIPTION DRUG LABEL	104
Gabapentin	NuCare Pharmaceuticals,Inc.	2024-04-11	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	Bryant Ranch Prepack	2024-04-03	HUMAN PRESCRIPTION DRUG LABEL	101
Gabapentin	Bryant Ranch Prepack	2024-04-03	HUMAN PRESCRIPTION DRUG LABEL	4
Gabapentin	Bryant Ranch Prepack	2024-04-02	HUMAN PRESCRIPTION DRUG LABEL	11
Gabapentin	ACI Healthcare USA, Inc. \| ACI HealthCare Limited \| Strides Pharma Science Limited \| Vivimed Life Sciences Private Limited	2023-12-17	HUMAN PRESCRIPTION DRUG LABEL	9
Gabapentin	NuCare Pharmaceuticals,Inc. \| NuCare Pharmceuticals,Inc.	2022-11-23	HUMAN PRESCRIPTION DRUG LABEL	2
Gabapentin	Bryant Ranch Prepack	2021-12-28	HUMAN PRESCRIPTION DRUG LABEL	5
Gabapentin	Preferred Pharmaceuticals, Inc.	2021-05-21	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	Preferred Pharmaceuticals, Inc.791119022 \| Preferred Pharmaceuticals, Inc.	2021-05-20	HUMAN PRESCRIPTION DRUG LABEL	3